ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01640912
Recruitment Status : Completed
First Posted : July 16, 2012
Last Update Posted : September 17, 2014
Sponsor:
Information provided by (Responsible Party):
RXi Pharmaceuticals, Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2014
  Actual Study Completion Date : May 2014